department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Ella · pharmadog

pharmadog
drugs
Ella

drug

patient view →

Ella

Marketedupdated 2mo ago

by HRA Pharma LLC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Ella

generic

ulipristal acetate

indication

Female Contraception

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Dec 8, 2028

~2.4 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (8)

Jun 12, 2030method-of-use (U-1389)US 84263923.9y
Jun 12, 2030method-of-use (U-1657)US 89626033.9y
Jun 2, 2030formulationUS 85127453.9y
Apr 13, 2030method-of-use (U-2510)US 101596813.8y
Apr 13, 2030method-of-use (U-2958)US 107728973.8y
Apr 13, 2030method-of-use (U-1821)US 92832333.8y
Feb 20, 2029formulationUS 87353802.6y
Dec 8, 2028formulationUS 98445102.4y

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 4

companyEmory University1 co-mentions · 1 sources
companyUniversity of Minnesota1 co-mentions · 1 sources
tagWomen's Health1 co-mentions · 1 sources
tagGene Therapy (AAV)1 co-mentions · 1 sources

Trials studying Ella

—Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shockrecruitingn=350
phase3A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)completedn=554
—Retrospective Kinetic Safety Evaluation of an Intravenous Micellar Excipient Platformnot yet recruitingn=625
phase3A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Agerecruitingn=911
phase3A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Populationrecruitingn=2,440
phase2Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinomarecruitingn=75
N/AINitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recoverynot yet recruitingn=250
N/AImpella ECP Early Feasibility Studyactive not recruitingn=100

more trials →